The Ministry of Public Health, in cooperation with Hamad Medical Corporation (HMC), organised a blood donation campaign.
The campaign witnessed a remarkable turnout from the employees of the Ministry of Public Health who came to the medical vehicle prepared for this purpose, which was located in front of the main entrance of the Ministry building.
The campaign, was overseen by the Social Committee at the Ministry with the aims to raise awareness among the employees about the importance of blood donation and its"...

The International Primary Health Care Conference will be held in Doha on November 17 and it provides an opportunity for primary health care experts to share knowledge and network with other professionals in a global and diverse platform, says a senior official.

Huda Al Wahidi, Executive Director of Corporate Communication at the Primary Health Care Corporation (PHCC), said that the significant preparations are being made within the Corporation to"...

(AETOS Wire)-- IPF is a progressive and debilitating disease which causes continual and irreversible damage to the lungs.1 Early diagnosis is vital because without appropriate medical intervention, the opportunity to slow disease progression is lost. However, diagnosis can be challenging.1,2This year for IPF World Week (16-24 September), Boehringer Ingelheim is raising awareness of ‘the sounds of IPF’ helping physicians recognise the velcro-like crackle which can be heard"...

• The CHMP of the EMA has issued a positive opinion for an update of the Summary of Product Characteristics (SmPC) for Pradaxa® (dabigatran etexilate)

• The CHMP recommends to include data showing that catheter ablation can be conducted in patients on 150 mg twice daily Pradaxa®, without interrupting Pradaxa® treatment

• In RE-CIRCUIT®, uninterrupted Pradaxa® showed less major bleeding than warfarin in atrial fibrillation patients undergoing catheter ablation

(...

• Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Cyltezo® (adalimumab biosimilar) for the treatment of multiple chronic inflammatory diseases
• Recommendation based on extensive analytical, pharmacological, non –clinical & clinical data, which demonstrated similarity of Cyltezo® /BI 695501 to Humira®
• Positive opinion follows the recent FDA approval of Cyltezo®1

(AETOS"...

Foundation for a Smoke-Free World Secures Major 12 Year Funding Commitment;

Shares Initial Plans to Reduce Harm and Deaths from Smoking Worldwide

(AETOS Wire)-- With the goal of eliminating smoking worldwide, the Foundation for a Smoke-Free World formally launched today in New York City. The Foundation is founded and led by Dr."...

(AETOS Wire)-- The company Swiss Advanced Vision (SAV-IOL SA) announced today the launch of LUCIDIS and EDEN, two new intraocular lenses (IOLs) for the cataract surgery, both using the Instant Focus EDOF patented technology. With a brand-new concept, LUCIDIS brings two major achievements for the monofocal market: extending the depth of focus on a monofocal lens while being the first affordable EDOF IOL. Thanks to its advanced refractive design, it allows an extension towards the near"...

Sidra Medical and Research Center (Sidra) has appointed Professor Gordan Vujanic (pictured), as Senior Attending Physician in Paediatric Pathology.
Prof Vujanic will be orking closely with Dr Adrian Charles, Chief of Anatomical Pathology and will be leading paediatric pathology services at Sidra. This includes fetal, perinatal and pediatric surgical pathology. Prof Vujanic is renowned for his work and international studies on paediatric renal tumors. In addition to his new role at Sidra, Prof. Vujanic is the Chair of"...

(AETOS Wire)-- Life Line Screening, a leader in community-based preventive healthcare, is deepening its delivery model of face-to-face patient care to provide access to advanced precision medicine through DNA testing and clinical trials.

This expansion is a natural outcome of the company’s already rigorous research arm, which has resulted in dozens of papers and presentations that analyze the company’s"...